NDC 16729-243
Topotecan
Topotecan
Topotecan is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Accord Healthcare Inc.. The primary component is Topotecan.
| Product ID | 16729-243_544d549e-a73d-24a5-e054-00144ff8d46c |
| NDC | 16729-243 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Topotecan |
| Generic Name | Topotecan |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-01-01 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA204406 |
| Labeler Name | Accord Healthcare Inc. |
| Substance Name | TOPOTECAN |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |